Register for our free email digests:
Division of UnitedHealth Group Co.
Latest From OptumRx Inc.
Express Scripts is losing its biggest customer, which could be a sign that plan sponsors are looking for more control over their pharmacy spending -- bad news for the big PBMs but good news for biopharma?
Health Transformation Alliance partners with CVS and OptumRx on project to lower drug spending in employer-sponsored insurance. Pilot effort expected to involve 20 corporations, save $600m over three years.
OptumRx, Harvard Pilgrim watching closely as Intercept’s Ocaliva nears market entry with claim for primary biliary cholangitis; use restrictions against off-label use in NASH are likely.
Biopharma financing totaled $9.7 billion, almost half from follow-on public offerings; there was big consolidation in the generics and health services industries. AstraZeneca signed a dozen partnerships, many of which focused on oncology.
- Therapeutic Areas
- Prescription Solutions
- North America
- Parent & Subsidiaries
- UnitedHealth Group Co.
- Senior Management
Timothy Wicks, CEO
Jeffrey Grosklags, CFO
- Contact Info
Phone: (800) 788-4863
2300 Main St.
Irvine, CA 92614
You must sign in to use this functionality
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.